Liposomes (NPs typically 100–500 nm in diameter) are fabricated from the self-assembly of phospholipids, which consist of a polar phosphate head group and hydrophobic lipid tails. The hydrophobic tails self-orient in aqueous environments, forming a spherical structure with an aqueous core and a lipophilic bilayer membrane surrounding it. Liposomes can be made to be both biocompatible and biodegradable (for instance, at a particular pH and temperature) by changing the lipid composition. Additionally, there are a number of modifications that can be made to liposomes to increase their effectiveness as drug delivery vehicles.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V73450 | Lipid 6 | 2226547-22-2 | Lipid 6 is an ionizable aminolipid that may be utilized to prepare lipid nanoparticles. |
|
V74078 | Lipid 8 | 2226547-25-5 | Lipid 8 is an ionizable aminolipid that may be utilized to prepare lipid nanoparticles. |
|
V60067 | Lipid A9 | 2036272-50-9 | Lipid A9 is an excipient for vaccines. |
|
V73460 | Lipid C24 | 2767561-52-2 | Lipid C24 is a cationic ionizable lipid that may be utilized in the synthesis/preparation of lipid nanoparticles (LNP). |
|
V73442 | Lipid M | 2089251-57-8 | Lipid M (pKa: 6.75) may be utilized to deliver mRNA vaccines to elicit robust immune responses and improve tolerance. |
|
V73427 | LNP Lipid-1 | 2089253-13-2 | LNP Lipid-1 (Method B) is a lipid compound. |
|
V73440 | LNP Lipid-3 | 2648693-32-5 | LNP Lipid-3 is an ionizable lipid that may be utilized to prepare lipid nanoparticles. |
|
V73443 | LNP Lipid-4 | 2795397-84-9 | LNP Lipid-4 (Compound 8-8) is a lipid compound. |
|
V73477 | LNP Lipid-5 | 2430034-00-5 | LNP Lipid-5 (Compound Lipid 2) is an ionizable lipid (aminolipid). |
|
V73482 | LNP Lipid-6 | 2226547-32-4 | LNP Lipid-6 (Compound Lipid 5) is an ionizable lipid (aminolipid). |
|
V73465 | LNP Lipid-7 | 1190203-55-4 | LNP Lipid-7 (Compound 7013) is a lipid. |
|
V81626 | m-PEG-NH2 hydrochloride (MW 2000) | m-PEG-NH2 ( HCl) (MW 2000) is a permeation-resistant compound involved in the preparation of mixed gels with adsorption and size exclusion chromatography (AdSEC) properties. | |
|
V73413 | m-PEG-thiol (MW 1000) (mPEG-SH (MW 1000)) | 134874-49-0 | m-PEG-thiol (MW 1000) can modify DNA thiolation and may be used in the synthesis/preparation of gold nanorods (AuNR). |
|
V81089 | Mal-NH-PEG-NH2 TFA (MW 2000) (Maleimide-NH-PEG-amine TFA (MW 2000)) | Mal-NH-PEG-NH2 (TFA) (MW 2000) is a PEG analogue that may be used for thiol PEGylation of protein molecules. | |
|
V73458 | MGlc-DAG | 2021179-21-3 | MGlc-DAG is a glycolipid glyceride that may be utilized in the preparation /synthesis of drug delivery compounds. |
|
V82221 | MOG peptide (79-96)rat | 356038-17-0 | MOG peptide (79-96) rat is a myelin oligodendrocyte glycoprotein with encephalitogenic effects. |
|
V73475 | mono-Pal-MTO | 1349197-89-2 | mono-Pal-MTO is a palm oil-based lipid produced by combining the anti-cancer active molecule mitoxantrone (MTO) with palmitoleic acid. |
|
V73425 | mPEG-CHO (MW 1000) (mPEG-Aldehyde (MW 1000)) | 70086-22-5 | mPEG-CHO (MW 1000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. |
|
V73432 | mPEG-CHO (MW 2000) (mPEG-Aldehyde (MW 2000)) | 70086-22-9 | mPEG-CHO (MW 2000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. |
|
V74060 | mPEG-DSPE (MW 2000) (Methoxy-poly(ethylene glycol)-distaroylphosphatidylethanolamine (MW 2000)) | 147867-65-0 | mPEG-DSPE (MW 2000) is a phospholipid-polyethylene glycol conjugate with both hydrophilic and hydrophobic properties. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
